Antenna Group

Chad Krulicki Joins Antenna Group as Senior Vice President, Executive Creative Director

NEW YORK–(BUSINESS WIRE)–Antenna Group, a global marketing communications agency focused on climate, mobility, real estate, and health, announced today that Chad Krulicki has joined its team as Senior Vice President, Executive Creative Director. Antenna is the primary resource for world-class brands leading sustainability conversations in the Age of Climate Adoption, providing its clients a range of creative services to elevate their brands and the stories they … Continue reading Chad Krulicki Joins Antenna Group as Senior Vice President, Executive Creative Director

Cambia Health Solutions

Cambia Health Solutions names Stephen Foxley as vice president of state affairs

PORTLAND, Ore.–(BUSINESS WIRE)–Cambia Health Solutions has promoted Stephen Foxley to serve as its next vice president of state affairs. In this role, Foxley will lead state government and regulatory affairs teams across Cambia’s four-state footprint. Under Foxley’s experienced leadership, Cambia teams will continue their focus on transforming the health care experience through political, legislative and regulatory policy strategies. “Stephen has a strong, proven track record … Continue reading Cambia Health Solutions names Stephen Foxley as vice president of state affairs

Amber Specialty Pharmacy

Jessica Ringena Named President of Amber Specialty Pharmacy

OMAHA, Neb.–(BUSINESS WIRE)–Amber Specialty Pharmacy announces the appointment of Jessica Ringena as its newest president. Ringena previously served as president of Vivid Clear Rx, a pharmacy benefit manager and subsidiary of Hy-Vee. Known for her strategic leadership in health care, technology, finance and innovation, Ringena will lead the specialty pharmacy in its mission to deliver personalized care to patients who experience chronic and complex conditions. … Continue reading Jessica Ringena Named President of Amber Specialty Pharmacy

Novo Integrated Sciences, Inc.

Novo Integrated Sciences Appoints New President

BELLEVUE, Wash.–(BUSINESS WIRE)–Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announces today Mr. Robert Oliva has been appointed as the Company’s new President. Mr. Oliva succeeds Mr. Christopher David, who remains as the Company’s Chief Operating Officer and as a member of the Company’s Board of Directors. Mr. Oliva has over 35 years of ownership and proven business development with expertise in manufacturing … Continue reading Novo Integrated Sciences Appoints New President

CSS

Alain Berinstain Joins CSS as Chief Strategy Officer

FAIRFAX, Va.–(BUSINESS WIRE)–CSS Inc, www.css-inc.com, an employee-owned, science-based solutions company serving both government and commercial customers, announces today the appointment of Dr. Alain Berinstain as its Chief Strategy Officer (CSO), effective February 12, 2024. “Our science-driven approach to helping our customers achieve their goals will be strengthened by a seasoned leader who is also a scientist, it’s really a perfect fit.”Post this Berinstain joins the executive … Continue reading Alain Berinstain Joins CSS as Chief Strategy Officer

Verily

Myoung Cha Joins Verily as Chief Product Officer

Former Carbon Health and Apple executive brings extensive experience developing technologies to advance clinical and virtual care models SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Verily, an Alphabet precision health technology company, today announced the appointment of Myoung Cha as Chief Product Officer. Cha will join Verily’s leadership team to lead strategy and development across the company’s care (Verily Onduo), research (Verily Viewpoint), and products (Verily Numetric) portfolio … Continue reading Myoung Cha Joins Verily as Chief Product Officer

Gilead Sciences

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Subscribili

Subscribili Secures $4.3M in Seed Funding to Revolutionize Dental Care Industry

AUSTIN, Texas–(BUSINESS WIRE)–In a bold move set to revolutionize the dental care industry and make a significant impact on the broader healthcare landscape, Subscribili, a pioneer in subscription-based healthcare, has secured a significant $4.3 million in seed funding. This investment, led by Darby Group Companies and supported by Vyne Dental, is also backed by other notable figures in the dental and technology industries. Among them are Gokul Rajaram, a distinguished … Continue reading Subscribili Secures $4.3M in Seed Funding to Revolutionize Dental Care Industry